Definitive Contract 75N93022C00005
Award Date
1/10/22
Potential Completion Date
1/9/24
Potential Value
$600K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Virtici LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98122, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
11
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $585,350 firm fixed price contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Virtici LLC, a small business limited liability company, to develop a novel adjuvant-based probiotic platform for generating tolerance therapeutics. The contract is part of the Small Business Innovation Research (SBIR) Program Phase I initiative. Virtici has extensive experience in federal biomedical research and development contracts and...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $22,595,588.82 cost-plus-fixed-fee definitive contract to Versatope Therapeutics Inc., a for-profit biotechnology company based in Lowell, Massachusetts. This contract, awarded under the HHS-NIH-NIAID-BAA2018 program, supports research to establish and improve biomedical knowledge on infectious diseases such as malaria. The contract has an ultimate completion date of June 28, 2025....
The Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $599,980 firm fixed price contract to Tendel Therapies, Inc., a small business, for research and development services related to genetic adjuvants to promote durable anti-influenza stem antibodies in older adults. This contract was awarded under the NIH and Centers for Disease Control and Prevention's Small Business Innovation Research (SBIR) program,...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, has awarded a $299,968 Small Business Innovation Research (SBIR) Phase I contract to Vitruvian Bio, LLC, a small disadvantaged and woman-owned business. The contract is for the development of an "Electrochemical Self-Monitoring Device for Rapid Nucleic Acid Based Testing of HIV-1". This specialized medical research and diagnostic technology...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $1.5M definitive contract to Via Therapeutics, LLC, doing business as Via Therapeutics LLC, located in Austin, Texas. The firm fixed price contract runs from September 15, 2023 through September 14, 2026 to support Via Therapeutics' Phase II award for small business innovation research related to developing new therapeutics. No subcontractors...
This federal contract award, valued at $39,790,398.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., to provide operational support for the NIAID Vaccine Research Center (VRC). The contract type is a Delivery Order with a Cost Plus Fixed Fee pricing structure, and the ultimate completion date is...
This is a $599,471.00 Firm Fixed Price Definitive Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to L2 Diagnostics LLC, a small business based in Woodbridge, Connecticut. The contract is for a Small Business Innovation Research (SBIR) Program Phase I project to develop a "Therapeutic Vaccine Platform to Boost Immune Responses in Tuberculosis". The contract has a total small business set-aside designation and a performance...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $299,995 firm fixed-price contract to Via Therapeutics, LLC, a small business located in Austin, Texas. The contract is for the development of low-cost, shelf-stable, patient-adaptable clofazimine mini-tablets to treat tuberculosis in pediatric patients. This contract supports Via Therapeutics' pharmaceutical research and development efforts related to...
This is a $599,234 firm fixed price contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to Celdara Medical, a small business biotechnology company, under the Small Business Innovation Research (SBIR) program. The contract is for research to discover parasite-derived tolerogenic adjuvants, which could potentially be used in new vaccine development. Celdara Medical conducts research and...